CTLA4 and multiple sclerosis: Abatacept consists of the extracellular domain of CTLA-4 and the Fc region of immunoglobulin G. It can bind with B7 molecules on the surface of antigen-presenting cells and inhibit T-cell activation by blocking the co-stimulatory signals to T cells in multiple sclerosis.